These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19107419)

  • 1. Preparation of sumoylated substrates for biochemical analysis.
    Knipscheer P; Klug H; Sixma TK; Pichler A
    Methods Mol Biol; 2009; 497():201-10. PubMed ID: 19107419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performing in vitro sumoylation reactions using recombinant enzymes.
    Werner A; Moutty MC; Möller U; Melchior F
    Methods Mol Biol; 2009; 497():187-99. PubMed ID: 19107418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
    J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms in SUMO conjugation.
    Varejão N; Lascorz J; Li Y; Reverter D
    Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO: getting it on.
    Anckar J; Sistonen L
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
    Niedenthal R
    Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SUMO-conjugated proteins and their SUMO attachment sites using proteomic mass spectrometry.
    Wohlschlegel JA
    Methods Mol Biol; 2009; 497():33-49. PubMed ID: 19107409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different proteomic strategies to identify genuine Small Ubiquitin-like MOdifier targets and their modification sites in Trypanosoma brucei procyclic forms.
    Iribarren PA; Berazategui MA; Bayona JC; Almeida IC; Cazzulo JJ; Alvarez VE
    Cell Microbiol; 2015 Oct; 17(10):1413-22. PubMed ID: 26096196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of SUMO-1 modified IκBα and complex formation with NF-κB.
    Lens Z; Dewitte F; Van Lint C; de Launoit Y; Villeret V; Verger A
    Protein Expr Purif; 2011 Dec; 80(2):211-6. PubMed ID: 21708266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO modification of the ubiquitin-conjugating enzyme E2-25K.
    Pichler A; Knipscheer P; Oberhofer E; van Dijk WJ; Körner R; Olsen JV; Jentsch S; Melchior F; Sixma TK
    Nat Struct Mol Biol; 2005 Mar; 12(3):264-9. PubMed ID: 15723079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cellular SUMO and SUMO-ubiquitin hybrid conjugates.
    Schnellhardt M; Uzunova K; Bade VN; Krause A; Weisshaar SR; Praefcke GJ; Dohmen RJ
    Methods Mol Biol; 2012; 832():81-92. PubMed ID: 22350877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Sumoylation.
    Breucker J; Pichler A
    Methods Mol Biol; 2019; 1934():223-233. PubMed ID: 31256382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubc9 sumoylation regulates SUMO target discrimination.
    Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
    Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).
    Wu YC; Roark AA; Bian XL; Wilson VG
    Virology; 2008 Sep; 378(2):329-38. PubMed ID: 18619639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
    Yunus AA; Lima CD
    Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum.
    Reiter K; Mukhopadhyay D; Zhang H; Boucher LE; Kumar N; Bosch J; Matunis MJ
    J Biol Chem; 2013 Sep; 288(39):27724-36. PubMed ID: 23943616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small ubiquitin-like modifier (SUMO)-conjugating system of Toxoplasma gondii.
    Braun L; Cannella D; Pinheiro AM; Kieffer S; Belrhali H; Garin J; Hakimi MA
    Int J Parasitol; 2009 Jan; 39(1):81-90. PubMed ID: 18761012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assay to determine SUMOylation sites on protein substrates.
    McManus FP; Altamirano CD; Thibault P
    Nat Protoc; 2016 Feb; 11(2):387-97. PubMed ID: 26820795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the SUMOylated landscape.
    Eifler K; Vertegaal AC
    FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.